Thymosin alpha 1: A comprehensive review of the literature - PMC
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. Division of Research and Academic Affairs, Larkin Health System, South Miami, FL 33143, United States Division of Research and Academic Affairs, Larkin Health System, South Miami, FL 33143, United States. moc.latipsohnikral@yawahtah.dlanod Division of Research and Academic Affairs, Larkin Health System, South Miami, FL 33143, United States Division of Research and Academic Affairs, Larkin Health System, South Miami, FL 33143, United States Division of Rese
Abstract Thymosin alpha 1 is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function. Thymosin alpha 1 has been utilized in the treatment of immunocompromised states and malignancies, as an enhancer of vaccine response, and as a means of curbing morbidity and mortality in sepsis and numerous infections. Studies have postulated that thymosin alpha 1 could help improve the outcome in severely ill corona virus disease 2019 patients by repairing damage caused by overactivation of lymphocytic immunity and how thymosin…
saved by
related reading
- The trinity of COVID-19: immunity, inflammation and interventionnature.com
- Effects of stress on immune function: the good, the bad, and the beautiful - PubMedpubmed.ncbi.nlm.nih.gov
- Immunotherapy for Cancer - NCIcancer.gov
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov
- Publications - O'Sullivan labosullivanlab.com
- Interferon-alpha/beta receptor - Wikipediaen.wikipedia.org
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Genetic susceptibility to Candida infectionsncbi.nlm.nih.gov
- Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children - PubMedpubmed.ncbi.nlm.nih.gov
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
- radvacradvac.org
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov